Literature DB >> 19850440

Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration.

Catherine Takacs Witkop1, Mark R Duffy, Elizabeth A Macias, Thomas F Gibbons, James D Escobar, Kristen N Burwell, Kenneth K Knight.   

Abstract

BACKGROUND: The U.S. Air Force Academy is an undergraduate institution that educates and trains cadets for military service. Following the arrival of 1376 basic cadet trainees in June 2009, surveillance revealed an increase in cadets presenting with respiratory illness. Specimens from ill cadets tested positive for novel influenza A (H1N1 [nH1N1])-specific ribonucleic acid (RNA) by real-time reverse transcriptase-polymerase chain reaction.
PURPOSE: The outbreak epidemiology, control measures, and nH1N1 shedding duration are described.
METHODS: Case patients were identified through retrospective and prospective surveillance. Symptoms, signs, and illness duration were documented. Nasal-wash specimens were tested for nH1N1-specific RNA. Serial samples from a subset of 53 patients were assessed for presence of viable virus by viral culture.
RESULTS: A total of 134 confirmed and 33 suspected cases of nH1N1 infection were identified with onset date June 25-July 24, 2009. Median age of case patients was 18 years (range, 17-24 years). Fever, cough, and sore throat were the most commonly reported symptoms. The incidence rate among basic cadet trainees during the outbreak period was 11%. Twenty-nine percent (31/106) of samples from patients with temperature <100 degrees F and 19% (11/58) of samples from patients reporting no symptoms for > or = 24 hours contained viable nH1N1 virus. Of 29 samples obtained 7 days from illness onset, seven (24%) contained viable nH1N1 virus.
CONCLUSIONS: In the nH1N1 outbreak under study, the number of cases peaked 48 hours after a social event and rapidly declined thereafter. Almost one quarter of samples obtained 7 days from illness onset contained viable nH1N1 virus. These data may be useful for future investigations and in scenario planning. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19850440     DOI: 10.1016/j.amepre.2009.10.005

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  36 in total

1.  Absolute humidity and pandemic versus epidemic influenza.

Authors:  Jeffrey Shaman; Edward Goldstein; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2010-11-16       Impact factor: 4.897

2.  Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendations.

Authors:  Christl A Donnelly; Lyn Finelli; Simon Cauchemez; Sonja J Olsen; Saumil Doshi; Michael L Jackson; Erin D Kennedy; Laurie Kamimoto; Tiffany L Marchbanks; Oliver W Morgan; Minal Patel; David L Swerdlow; Neil M Ferguson
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

3.  Influenza A(H1N1)pdm09 during air travel.

Authors:  John Neatherlin; Elaine H Cramer; Christine Dubray; Karen J Marienau; Michelle Russell; Hong Sun; Melissa Whaley; Kathy Hancock; Krista K Duong; Hannah L Kirking; Christopher Schembri; Jacqueline M Katz; Nicole J Cohen; Daniel B Fishbein
Journal:  Travel Med Infect Dis       Date:  2013-03-21       Impact factor: 6.211

Review 4.  Evaluation of the spread of pandemic influenza A/H1N1 2009 among Japanese university students.

Authors:  Mitsuo Uchida; Minoru Kaneko; Teruomi Tsukahara; Shinsuke Washizuka; Shigeyuki Kawa
Journal:  Environ Health Prev Med       Date:  2014-07-04       Impact factor: 3.674

Review 5.  How I treat influenza in patients with hematologic malignancies.

Authors:  Corey Casper; Janet Englund; Michael Boeckh
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

6.  CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination.

Authors:  Junbao Yang; Eddie James; Theresa J Gates; Jonathan H DeLong; Rebecca E LaFond; Uma Malhotra; William W Kwok
Journal:  Int Immunol       Date:  2013-03-22       Impact factor: 4.823

7.  Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis.

Authors:  Tran Tinh Hien; Maciej F Boni; Juliet E Bryant; Tran Thuy Ngan; Marcel Wolbers; Tran Dang Nguyen; Nguyen Thanh Truong; Nguyen Thi Dung; Do Quang Ha; Vo Minh Hien; Tran Tan Thanh; Le Nguyen Truc Nhu; Le Thi Tam Uyen; Pham Thi Nhien; Nguyen Tran Chinh; Nguyen Van Vinh Chau; Jeremy Farrar; H Rogier van Doorn
Journal:  PLoS Med       Date:  2010-05-18       Impact factor: 11.069

8.  Contagious period for pandemic (H1N1) 2009.

Authors:  Gaston De Serres; Isabelle Rouleau; Marie Eve Hamelin; Caroline Quach; Danuta Skowronski; Louis Flamand; Nicole Boulianne; Yan Li; Julie Carbonneau; Annemarie Bourgault; Michel Couillard; Hugues Charest; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

9.  Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.

Authors:  Hongjie Yu; Qiaohong Liao; Yuan Yuan; Lei Zhou; Nijuan Xiang; Yang Huai; Xiuhua Guo; Yingdong Zheng; H Rogier van Doorn; Jeremy Farrar; Zhancheng Gao; Zijian Feng; Yu Wang; Weizhong Yang
Journal:  BMJ       Date:  2010-09-28

10.  H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.

Authors:  Thiago Moreno L Souza; Jorge I F Salluh; Fernando A Bozza; Milene Mesquita; Márcio Soares; Fernando C Motta; Melissa Tassano Pitrowsky; Maria de Lourdes Oliveira; Vasiliy P Mishin; Larissa V Gubareva; Anne Whitney; Sandra Amaral Rocco; Vânia Maria C Gonçalves; Venceslaine Prado Marques; Eduardo Velasco; Marilda M Siqueira
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.